NASDAQ:CTRV
Delisted
ContraVir Pharmaceuticals Inc Stock Company Profile
$1.23
+0 (+0%)
At Close: May 27, 2022
Information
399 Thornall Street
Edison NJ 08837
732-902-4000
www.contravir.com
Description
ContraVir Pharmaceuticals, Inc. operates as a biopharmaceutical company focused on the development of antiviral drugs with a primary emphasis on the treatment of Hepatitis B virus (HBV) infections. The company is developing CMX157 and CRV431 to treat HBV infection; and FV-100, an orally available, small molecule compound for the prevention of post-herpetic neuralgia, and treatment of herpes zoster infection and acute zoster-associated pain. ContraVir Pharmaceuticals, Inc. was founded in 2013 and is headquartered in Edison, New Jersey.
